Forge Biologics

Forge Biologics, headquartered in Columbus, Ohio, is a leading gene therapy development engine dedicated to making life-changing gene therapies accessible for patients. The company operates as a hybrid contract development and manufacturing organization (CDMO), providing comprehensive solutions that drive the development of innovative gene therapies from the discovery stage through to delivery. By collaborating with a wide range of partners, including biotech firms, academic institutions, and patient advocates, Forge aims to streamline the process of bringing transformative medicines to market.

The facilities at Forge Biologics represent a significant investment in cutting-edge technology to support the complex needs of gene therapy development. Their state-of-the-art manufacturing capabilities are designed to support the production of adeno-associated virus (AAV) vectors, a key component in many gene therapy products. Forge is committed to a patient-first approach, ensuring that their work profoundly impacts the lives of individuals suffering from severe genetic conditions. With ongoing projects and advancements such as their FUEL™ AAV manufacturing platform, Forge continues to be at the forefront of biopharmaceutical innovation, striving for excellence in every aspect of gene therapy production and development.